title: [Studies on poly-D, L-lactide acid scaffolds modified by conjugation of bioactive peptides via ammonia plasma treatment].
abstract: OBJECTIVE
  To study the feasibility of preparation of the poly-D, L-lactide acid (PDLLA) scaffolds treated by ammonia plasma and subsequent conjugation of Gly-Arg-Gly-Asp-Ser (GRGDS) peptides via amide linkage formation.
  
  
  METHODS
  PDLLA scaffolds (8 mm diameter, 1 mm thickness) were prepared by solvent casting/particulate leaching procedure and then treated by ammonia plasma. The consequent scaffolds were labeled as aminated PDLLA (A/PDLLA). The pore size, porosity, and surface water contact angle of groups 0 (un-treated control), 5, 10, and 20 minutes A/PDLLA were measured. A/PDLLA scaffolds in groups above were immersed into the FITC labelled GRGDS aqueous solution which contain 1-[3-(dimethylamino) propyl]-3-ethylcarbodiimide hydrochloride (EDC-HCl) and N-hydroxysuccinimide (NHS), the molar ratio of peptides/EDC*HCL/NHS was 1.5 : 1.5 : 1.0, then brachytely slashed for 24 hours in room temperature. The consequent scaffolds were labelled as peptides conjugated A/PDLLA (PA/PDLLA). The scaffolds in groups 0, 5, 10, and 20 minutes A/PDLLA and groups correspondingly conjugation of peptides were detected using X-ray photoelectron spectroscopy (XPS). The scaffolds in groups of conjugation of peptides were measured by confocal laser scanning microscope and high performance liquid chromatography (HPLC), un-treated and un-conjugated scaffolds employed as control. Bone marrow mesenchymal stem cells (BMSCs) from SD rats were isolated and cultured by whole bone marrow adherent culture method. BMSCs at the 3rd-6th passages were seeded to the scaffolds as follows: 20 minutes ammonia plasma treatment (group A/PDLLA), 20 minutes ammonia plasma treatment and conjugation of GRGDS (group PA/PDLLA), and untreated PDLLA control (group PDLLA). After 16 hours of culture, the adhesive cells on scaffolds and the adhesive rate were calculated. After 4 and 8 days of culture, the BMSCs/scaffold composites was observed by scanning electron microscope (SEM).
  
  
  RESULTS
  No significant difference in pore size and porosity of PDLLA were observed between before and after ammonia plasma treatments (P > 0.05). With increased time of ammonia plasma treatment, the water contact angle of A/PDLLA scaffolds surface was decreased, and the hydrophilicity in the treated scaffolds was improved gradually, showing significant differences when these groups were compared with each other (P < 0.001). XPS results indicated that element nitrogen appeared on the surface of PDLLA treated by ammonia plasma. With time passing, the peak N1s became more visible, and the ratio of N/C increased more obviously. After PDLLA scaffolds treated for 0, 5, 10, and 20 minutes with ammonia plasma and subsequent conjugation of peptides, the ratio of N/C increased and the peak of S2p appeared on the surface. The confocal laser scanning microscope observation showed that the fluorescence intensity of PA/PDLLA scaffolds increased obviously with treatment time. The amount of peptides conjugated for 10 minutes and 20 minutes PA/PDLLA was detected by HPLC successfully, showing significant differences between 10 minutes and 20 minutes groups (P < 0.001). However, the amount of peptides conjugated in un-treated control and 0, 5 minutes PA/PDLLA scaffolds was too small to detect. After 16 hours co-culture of BMSCs/scaffolds, the adhesive cells and the adhesive rates of A/PDLLA and PA/PDLLA scaffolds were higher than those of PDLLA scaffolds, showing significant difference between every 2 groups (P < 0.01). Also, SEM observation confirmed that BMSCs proliferation in A/PDLLA and PA/PDLLA groups was more detectable than that in PDLLA group, especially in PA/PDLLA group.
  
  
  CONCLUSIONS
  Ammonia plasma treatment will significantly increase the amount of FITC-GRGDS peptides conjugated to surface of PDLLA via amide linkage formation. This new type of biomimetic bone has stabilized bioactivities and has proved to promote the adhesion and proliferation of BMSCs in PDLLA.
authors.affiliation: Department of Spinal and Orthopedic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou Guangdong 510515, PR China.
authors.forename: Zixing
authors.initials: Z
authors.lastname: Xu
authors.forename: Jianting
authors.initials: J
authors.lastname: Chen
authors.forename: Shiheng
authors.initials: S
authors.lastname: Yin
authors.forename: Qing'an
authors.initials: Q
authors.lastname: Zhu
authors.forename: Tao
authors.initials: T
authors.lastname: Li
authors.forename: Dingsheng
authors.initials: D
authors.lastname: Zha
authors.forename: Xiaorui
authors.initials: X
authors.lastname: Jiang
authors.forename: Xinxin
authors.initials: X
authors.lastname: Zhang
mesh_terms: D000641:Ammonia / Q000737:chemistry; D000818:Animals; D001672:Biocompatible Materials; D005260:Female; D019344:Lactic Acid / Q000737:chemistry*; D008297:Male; D010455:Peptides; D011091:Polyesters; D011108:Polymers / Q000737:chemistry*; D051381:Rats; D017207:Rats, Sprague-Dawley; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds
chemical_list: D001672:Biocompatible Materials; D010455:Peptides; D011091:Polyesters; D011108:Polymers; D019344:Lactic Acid; C033616:poly(lactide); D000641:Ammonia